Study: Dantrolene Should be Stocked to Control Malignant Hyperthermia for all Anesthetics

Researchers looked at whether or not it was necessary to stock dantrolene, a drug used to treat malignant hyperthermia, at facilities using succinylcholine alone instead of volatile anesthetics, according to Anesthesia-Analgesia.

Advertisement

While the study observed if succinylcholine triggered MH, their methods provided little insight. The risk of MH with versus without succinylcholine both exceeded 1.

Researchers concluded that until more epidemiologic data is collected, having dantrolene available where both succinylcholine and volatile anesthetics are administers should be continued.

More Articles on Anesthesia:
MEDNAX Acquires Tennessee Anesthesia, Texas Pediatric Surgery Practices
Ethnicities Tied to Children’s Pain Scores
Class 1 Recall Issued for Ventlab’s Manual Resuscitators

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.